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Abstract
Background—Kleptomania (Compulsive Stealing) remains poorly understood with limited data 
regarding its underlying pathophysiology and appropriate treatment choices.
Methods—112 adults aged 18 to 65 with a primary, current diagnosis of kleptomania were 
assessed for the severity of their stealing behavior and urges to steal, along with related mental 
health symptoms. To identify clinical and demographic measures associated with variation in 
disease severity, we utilized the statistical technique of partial least squares (PLS).
Results—Greater kleptomania symptom severity was associated with having more frequent urges 
to steal, feeling excited by stealing, having a current eating disorder, and having a current 
diagnosis of OCD. Furthermore, worse symptom severity was associated with a shorter transition 
time (between first stealing and developing kleptomania), as well as with more chance of stealing 
from relatives and seeking treatment at some point.
Conclusions—Feeling some type of reward from stealing and co-occurrence of certain disorders 
associated with compulsivity (OCD, anorexia nervosa) were strongly associated with worse illness 
severity in kleptomania. Treatment approaches should incorporate these as possible treatment 
targets. These data may also support conceptualization of kleptomania as an obsessive-compulsive 
related disorder rather than being allied to substance use or impulsive disorders.
Introduction
Kleptomania is characterized by repetitive stealing behavior precipitated by significant and 
uncontrollable urges to steal items not needed for their personal use (1). The National 
Epidemiologic Survey on Alcohol and Related Conditions (NESARC) assessed rates of 
stealing (not a formal diagnosis of kleptomania) among 43,000 adults. The lifetime 
prevalence of shoplifting in the United States population was 11.3% (2). Although no large 
scale epidemiologic studies have been conducted to assess the prevalence of kleptomania in 
the general population, a survey of college students (N=791) found that 3 (0.38%) met 
criteria for kleptomania (3), suggesting that this disorder is relatively uncommon and/or that 
it is often concealed.
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The behaviors that characterize kleptomania (e.g., urges to steal, inability to stop) might be 
conceptualized as impulsive in that they are often premature, poorly thought out, risky, and 
result in deleterious long-term outcomes. Psychological testing has, in some studies, 
demonstrated greater cognitive impulsivity, larger deficits in inhibition, and greater 
sensation-seeking among individuals with kleptomania compared to controls (4). One 
neuroimaging study comparing individuals with kleptomania to healthy controls found 
decreased white matter microstructural integrity in inferior frontal brain regions consistent 
with difficulties in impulse control (5). Alternatively, kleptomania could be viewed as 
compulsive in that stealing without getting caught requires fore-planning; and involves a 
complex rewarding behavior (as opposed to unplanned impulses) (6–7).
Despite being described in the medical literature for nearly two hundred years (8), 
kleptomania still remains poorly understood with limited data regarding its underlying 
pathophysiology and appropriate treatment choices. There has been only one placebo-
controlled trial of pharmacotherapy published for the treatment of kleptomania. In that study, 
25 subjects were randomized in a 1:1 fashion to either naltrexone or placebo for 8 weeks (9). 
By study endpoint, 66.7% of those assigned to naltrexone compared to 7.7% on placebo (p<.
001) reported symptom remission. To date, there have been no controlled clinical trials of 
any psychosocial interventions for kleptomania. Thus, data are still lacking regarding 
optimal treatment options, duration and who with kleptomania would benefit more from 
medication or psychotherapy.
One approach to refining our treatment of kleptomania might be to better understand the 
range of illness severity and the clinical associations with severity. The DSM-5 criteria 
stipulate the minimal level of severity to meet diagnostic threshold (i.e. recurrent failure to 
resist impulses to steal objects) but do not provide details about severity levels and whether 
those can be meaningful in terms of treatment approaches. Thus the goal of this study was to 
identify clinical and demographic measures associated with variation in disease severity in a 
large sample of adults with kleptomania. Given the associations between impulsivity, 
compulsivity, and kleptomania (4, 6), we hypothesized that greater kleptomania symptom 
severity would be associated with a greater degree of both.
Methods
Subjects
Men and women aged 18 to 65 with a primary, current DSM-5 diagnosis of kleptomania 
(“primary” kleptomania was defined by the participant as the primary problem for which 
they sought help) were recruited by newspaper advertisements and referrals for 
neuroimaging or treatment studies (criteria for kleptomania were left unchanged from DSM-
IV to DSM-5 and therefore participants seen prior to DSM-5 continued to meet the criteria). 
Exclusion criteria included: 1) unstable medical illness; 2) history of seizures; 3) lifetime 
history of bipolar disorder, dementia, or psychotic disorder; 4) current (past 3 months) 
substance use disorder; 5) current risk of suicide (defined as endorsing any symptom on the 
Columbia Suicide Severity Scale) (10); and 6) current pregnancy or inadequate 
contraception in women of childbearing potential.
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Data were collected from July, 2005 to June, 2012 at the University of Minnesota and then 
from December, 2012 to the present time at the University of Chicago. The Institutional 
Review Boards for the University of Minnesota and the University of Chicago approved the 
studies and the informed consent procedures. After complete description of the studies and 
an opportunity to ask questions, participants provided written informed consent. This 
research was carried out in accordance with the principles of the Declaration of Helsinki.
Assessments
The diagnosis of kleptomania was made using the Structured Clinical Interview for 
Kleptomania (SCI-K) (11). Demographics and clinical features of kleptomania were 
assessed with a semi-structured interview. The semi-structured interview included questions 
regarding the phenomenology of kleptomania. Race/ethnicity was defined by the study 
subjects and was included to learn more about this variable in kleptomania. Psychiatric 
comorbidity was assessed using the Structured Clinical Interview for DSM-IV (SCID) (12).
All participants were assessed for the severity of their kleptomania symptoms using the 
clinician-rated Clinical Global Impression Severity scale (CGI-S) (13). The CGI-S is a 7-
point scale that requires the clinician to rate the severity of the patient's illness at the time of 
assessment using a range of responses from 1 (normal) through to 7 (amongst the most 
severely ill patients).
Depressive and anxiety symptoms were further assessed using the following valid and 
reliable clinician-administered measures: Hamilton Anxiety Rating Scale (HAM-A) (14), 
and Hamilton Depression Rating Scale (HAM-D) (15).
In addition, to examine impulsivity, each participant completed the Eysenck Impulsiveness 
Questionnaire (EIQ) (16). The EIQ is a 54 question self-report measure comprised of three 
subscales: impulsivity, venturesomeness, and empathy.
Data Analysis
To identify clinical and demographic measures associated with variation in disease severity, 
we utilized the statistical technique of partial least squares (PLS) (17–20). PLS is a 
multivariate, iterative technique that constructs one or more latent factors (referred to as PLS 
components) that optimally explain variation in X and Y. The Y variable was the score on 
the CGI-S and X variables were as follows: age, educational level, gender, age when starting 
stealing, time between starting to steal and feeling it was out of control, history of 
kleptomania or substance use disorder in one or more first-degree relatives, current smoking 
status (smoker or non-smoker), Hamilton Anxiety and Depression scale total scores, triggers 
to stealing, presence of major depressive disorder, presence of any anxiety disorder, presence 
of any substance use disorder, presence of OCD, presence of ADHD, legal issues, and 
Eysenck scores (impulsivity, empathy, venturesomeness). Unlike traditional regression, PLS 
is ideal in situations in which variables are correlated with each other; and when the number 
of variables is large in comparison to the number of cases, as was the case here (17–20). 
Analysis was conducted using JMP Pro software Version 13.0. Any missing data points were 
imputed automatically by JMP using study means. The PLS model was fitted using leave-
one-out cross-validation (non-linear iterative partial least squares, NIPALS algorithm), and 
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the optimal number of latent factors was selected by minimizing the predictive residual sum 
of the squares (PRESS). X variables significantly contributing to the model (i.e. explaining 
significant variance in disease severity) were identified on the basis of 95% confidence 
intervals for bootstrap distribution of the standardized model coefficients not crossing zero 
(N=1000 bootstraps).
Results
A total sample of 112 participants (mean age = 39.2 ± standard deviation 14.9 years; 71.4% 
female) were recruited. The participants reported a mean age at the onset of stealing of 17.5 
(11.9) years. The mean score on the CGI-S was 5.0 (1.1) [range 3 to 7]. The mean amount of 
current stealing was 1.5 (1.8) times per week. 71 (63.4%) had been arrested in their lifetime 
due to shoplifting.
Cross-validation showed that the optimal fit PLS model to minimize PRESS had one latent 
variable (Figure 1) and hence this model was selected. This model accounted for total 6.6% 
of the variation in the clinical/demographic measures, and 42.5% of variation in disease 
severity (CGI-S scores).
The standardized model coefficients for each variable of interest are presented in Table 1. 
Variables with positive coefficients had a positive relationship with CGI-S scores, and vice 
versa. Those measures shown in bold and with an asterisk retained statistical significance by 
bootstrap, i.e. the 95% confidence interval of the bootstrap distribution of the model 
coefficient did not cross zero. Thus, greater kleptomania symptom severity was significantly 
associated with having more frequent urges to steal, spouses knowing about the person’s 
stealing, stealing from relatives, having OCD, having an eating disorder, mood affecting 
stealing, experiencing urges when trying to quit stealing, getting excited when stealing, and 
having tried to quit. Greater kleptomania symptom severity was also significantly associated 
with lower ADHD symptoms, shorter lag time (shorter period between first stealing act and 
developing kleptomania), and lower family history of substance use disorder (s).
Discussion
To our knowledge, this is the first study to examine the clinical correlates of illness severity 
in a large sample of adults with kleptomania. There were several important findings from 
this analysis, which was conducted using the statistical methodology of partial least squares 
(PLS). This technique optimally explained the co-variation between demographic/clinical 
measures and symptom severity by constructing a single latent factor from the data. 
Frequency of urges to steal, reporting a positive feeling from the act of stealing, and certain 
comorbidities (anorexia nervosa, bulimia nervosa, and OCD) were significantly and 
positively associated with illness severity. Aspects of impulsivity (specifically domains EIQ) 
were not significantly associated with illness severity, and in fact ADHD was significantly 
associated with lower levels of illness severity.
Taken together, these data suggest that very specific clinical variables are associated with 
illness severity in kleptomania and they are also begin to suggest where kleptomania may fit 
in the taxonomy of psychiatric disorders. The urges to steal and the rewarding emotional 
Grant and Chamberlain Page 4









aspects of stealing were associated with greater illness severity. Interestingly, some 
traditional aspects of impulsivity (EIQ, ADHD) were not significantly and positively 
associated with greater kleptomania symptoms. On the other hand, compulsivity (categorical 
OCD and anorexia nervosa) was significantly and positively associated with illness severity 
in the model. These findings suggest that the rewarding aspects of stealing appear important 
in terms of disease severity but so too is the presence or absence of some compulsive 
disorders. More severe kleptomania symptoms were also linked, in the PLS model, with 
more likelihood of stealing from relatives and (perhaps due to this) with spouses being more 
likely to know about their partners’ stealing behaviors; as well as with trying to quit at some 
point, and a shorter transition time, as one may expect. Surprisingly, we found that worse 
symptoms were associated with a lower rather than higher chance of having a first-degree 
relative with a substance use disorder. One possible explanation is that those with some 
genetic or familial protection against substance addiction may manifest other compulsive 
behaviors.
The association of worse kleptomania severity with stealing-related reward and disorders of 
compulsivity (OCD, anorexia nervosa) may provide clues to appropriate targets for 
cognitive behavioral therapy or pharmacotherapy. Medications capable of dampening urges 
(such as naltrexone and others) may be worth exploring in clinical trials. However, the 
addition of compulsivity as a target may suggest that different subgroups of individuals with 
kleptomania may need treatments focusing on different targets or that a combination of 
approaches to dampening reward and improving compulsivity may be needed 
simultaneously.
Although this study represents a potentially beneficial approach to understanding 
kleptomania, there exist several limitations. Our approach of defining the statistical 
significance of individual measures in the PLS model by using bootstrap is quite 
conservative and so some variables may have been overlooked (false negatives). However, 
this approach does mean that one can have a high degree of statistical confidence in the 
significant results (low risk of false positive error). As with any such study, the current data 
cannot show that the findings would generalize to kleptomania patients presenting in other 
settings such as to family doctors.
From these findings, it seems that aspects of reward and compulsivity are both strongly 
associated with worse illness severity in kleptomania. As such, treatment approaches should 
incorporate these as possible treatment targets when developing new treatment approaches to 
this disorder.
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Figure 1. Predictive residual sum of the squares (PRESS) as a function of the number of latent 
factors.
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Table 1
Standardized model coefficients for each X variable of interest in the optimal PLS model 
(one latent variable). * : statistically significant predictive variable by bootstrap.
Coefficient CGI
Days per week have urges * 0.1291
Does Spouse Know * 0.0986




Mood Effect from Stealing * 0.0795
Urges When tried to Quit * 0.0778
Excited When Stealing * 0.0615
Education 0.0548
Gender 0.0425
Triggered by loneliness 0.0414
Age When Started Stealing 0.0404
Have Tried to Quit * 0.0344
Triggered by boredom 0.0314
MDD 0.0240
Race 0.0175
Family history of stealing 0.0107







Smoking packs per day -0.0239
Anxiety D/O Nos -0.0298
ADHD * -0.0341
Triggered by feeling anxious -0.0429
Age -0.0526
Lagtime (years) * -0.0535
Family history of AUD * -0.0631
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